Speaker: Jason Kihyuk Lee, MD, FRCPC, FAAAAI, FACAAI, Toronto Allergists, Toronto, ON
Moderator: Andréanne Côté, MD, FRCPC, Université Laval, Quebec City, QC

Type 2 inflammatory diseases are characterized by common shared immune dysregulation, which results in disease and organ specific signs and symptoms, impaired QoL and high burden of traditional standard-of-care treatments. It is commonly associated with an increased presence of other coexisting type 2 inflammatory diseases owing to the same dysregulation. This coexistence of comorbidities increases the patient’s overall disease burden, including impact on other type 2 driven dermatologic, respiratory and gastrointestinal diseases. Understanding the interrelationships will help the Respirologist optimize care for patients being treated.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Review the pathophysiology of type 2 diseases and with common inflammatory pathways;
  • Understand basic science and clinical evidence and how it is clinically relevant; and
  • Integrate throughout cases that illustrate type 2 coexisting diseases.

CanMEDS Roles: Collaborator, Communicator, Health Advocate, Leader, Medical Expert, Professional, Scholar

Click here for session invitation

This session is co-developed by the Canadian Thoracic Society and Sanofi and is planned to achieve scientific integrity, objectivity and balance.